BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma October 21, 2024
Maharashtra CET cell warns of legal action against private colleges stalling medical admissions October 4, 2024
Cell Impact enhances production capacity through an agreement with Andritz Soutec AG September 27, 2024